Selected research
Industry Growth & Trends
Global Animal-derived Immune Globulin Industry Growth and Trends Forecast to 2032
Market perspective
The global Animal-derived Immune Globulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Animal-derived Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Animal-derived Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Animal-derived Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Animal-derived Immune Globulin include Sanofi, Merck, Pfizer, Wyeth Pharmaceuticals, Rare Disease Therapeutics, Protherics and Genzyme, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Animal-derived Immune Globulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Animal-derived Immune Globulin market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Animal-derived Immune Globulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Animal-derived Immune Globulin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Animal-derived Immune Globulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Animal-derived Immune Globulin Market by Company
Sanofi
Merck
Pfizer
Wyeth Pharmaceuticals
Rare Disease Therapeutics
Protherics
Genzyme
Animal-derived Immune Globulin Segment by Type
Liquid
Powder
Animal-derived Immune Globulin Segment by Application
Hospital
Clinic
Animal-derived Immune Globulin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal-derived Immune Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal-derived Immune Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal-derived Immune Globulin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal-derived Immune Globulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Animal-derived Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Powder
Applications
- Hospital
- Clinic
Companies covered
- Sanofi
- Merck
- Pfizer
- Wyeth Pharmaceuticals
- Rare Disease Therapeutics
- Protherics
- Genzyme
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Animal-derived Immune Globulin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Animal-derived Immune Globulin Sales Estimates and Forecasts (2021-2032)
- 1.3 Animal-derived Immune Globulin Market by Type
- 1.3.1 Liquid
- 1.3.2 Powder
- 1.4 Global Animal-derived Immune Globulin Market Size by Type
- 1.4.1 Global Animal-derived Immune Globulin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Animal-derived Immune Globulin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Animal-derived Immune Globulin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Animal-derived Immune Globulin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Animal-derived Immune Globulin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Animal-derived Immune Globulin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Animal-derived Immune Globulin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Animal-derived Immune Globulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Animal-derived Immune Globulin Industry Trends
- 2.2 Animal-derived Immune Globulin Industry Drivers
- 2.3 Animal-derived Immune Globulin Industry Opportunities and Challenges
- 2.4 Animal-derived Immune Globulin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Animal-derived Immune Globulin Revenue (2021-2026)
- 3.2 Global Top Players by Animal-derived Immune Globulin Sales (2021-2026)
- 3.3 Global Top Players by Animal-derived Immune Globulin Price (2021-2026)
- 3.4 Global Animal-derived Immune Globulin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Animal-derived Immune Globulin Major Company Production Sites & Headquarters
- 3.6 Global Animal-derived Immune Globulin Company, Product Type & Application
- 3.7 Global Animal-derived Immune Globulin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Animal-derived Immune Globulin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Animal-derived Immune Globulin Players Market Share by Revenue in 2025
- 3.8.3 2025 Animal-derived Immune Globulin Tier 1, Tier 2, and Tier 3
4 Animal-derived Immune Globulin Regional Status and Outlook
- 4.1 Global Animal-derived Immune Globulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Animal-derived Immune Globulin Historic Market Size by Region
- 4.2.1 Global Animal-derived Immune Globulin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Animal-derived Immune Globulin Sales in Value by Region (2021-2026)
- 4.2.3 Global Animal-derived Immune Globulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Animal-derived Immune Globulin Forecasted Market Size by Region
- 4.3.1 Global Animal-derived Immune Globulin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Animal-derived Immune Globulin Sales in Value by Region (2027-2032)
- 4.3.3 Global Animal-derived Immune Globulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Animal-derived Immune Globulin by Application
- 5.1 Animal-derived Immune Globulin Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Animal-derived Immune Globulin Market Size by Application
- 5.2.1 Global Animal-derived Immune Globulin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Animal-derived Immune Globulin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Animal-derived Immune Globulin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Animal-derived Immune Globulin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Animal-derived Immune Globulin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Animal-derived Immune Globulin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Animal-derived Immune Globulin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Animal-derived Immune Globulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sanofi Animal-derived Immune Globulin Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck Animal-derived Immune Globulin Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Animal-derived Immune Globulin Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Wyeth Pharmaceuticals
- 6.4.1 Wyeth Pharmaceuticals Company Information
- 6.4.2 Wyeth Pharmaceuticals Business Overview
- 6.4.3 Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolio
- 6.4.5 Wyeth Pharmaceuticals Recent Developments
- 6.5 Rare Disease Therapeutics
- 6.5.1 Rare Disease Therapeutics Company Information
- 6.5.2 Rare Disease Therapeutics Business Overview
- 6.5.3 Rare Disease Therapeutics Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolio
- 6.5.5 Rare Disease Therapeutics Recent Developments
- 6.6 Protherics
- 6.6.1 Protherics Company Information
- 6.6.2 Protherics Business Overview
- 6.6.3 Protherics Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Protherics Animal-derived Immune Globulin Product Portfolio
- 6.6.5 Protherics Recent Developments
- 6.7 Genzyme
- 6.7.1 Genzyme Company Information
- 6.7.2 Genzyme Business Overview
- 6.7.3 Genzyme Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Genzyme Animal-derived Immune Globulin Product Portfolio
- 6.7.5 Genzyme Recent Developments
7 North America by Country
- 7.1 North America Animal-derived Immune Globulin Sales by Country
- 7.1.1 North America Animal-derived Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Animal-derived Immune Globulin Sales by Country (2021-2026)
- 7.1.3 North America Animal-derived Immune Globulin Sales Forecast by Country (2027-2032)
- 7.2 North America Animal-derived Immune Globulin Market Size by Country
- 7.2.1 North America Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Animal-derived Immune Globulin Market Size by Country (2021-2026)
- 7.2.3 North America Animal-derived Immune Globulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Animal-derived Immune Globulin Sales by Country
- 8.1.1 Europe Animal-derived Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Animal-derived Immune Globulin Sales by Country (2021-2026)
- 8.1.3 Europe Animal-derived Immune Globulin Sales Forecast by Country (2027-2032)
- 8.2 Europe Animal-derived Immune Globulin Market Size by Country
- 8.2.1 Europe Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Animal-derived Immune Globulin Market Size by Country (2021-2026)
- 8.2.3 Europe Animal-derived Immune Globulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Animal-derived Immune Globulin Sales by Country
- 9.1.1 Asia-Pacific Animal-derived Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Animal-derived Immune Globulin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Animal-derived Immune Globulin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Animal-derived Immune Globulin Market Size by Country
- 9.2.1 Asia-Pacific Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Animal-derived Immune Globulin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Animal-derived Immune Globulin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Animal-derived Immune Globulin Sales by Country
- 10.1.1 South America Animal-derived Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Animal-derived Immune Globulin Sales by Country (2021-2026)
- 10.1.3 South America Animal-derived Immune Globulin Sales Forecast by Country (2027-2032)
- 10.2 South America Animal-derived Immune Globulin Market Size by Country
- 10.2.1 South America Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Animal-derived Immune Globulin Market Size by Country (2021-2026)
- 10.2.3 South America Animal-derived Immune Globulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Animal-derived Immune Globulin Sales by Country
- 11.1.1 Middle East and Africa Animal-derived Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Animal-derived Immune Globulin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Animal-derived Immune Globulin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Animal-derived Immune Globulin Market Size by Country
- 11.2.1 Middle East and Africa Animal-derived Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Animal-derived Immune Globulin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Animal-derived Immune Globulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Animal-derived Immune Globulin Value Chain Analysis
- 12.1.1 Animal-derived Immune Globulin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Animal-derived Immune Globulin Production Mode & Process
- 12.2 Animal-derived Immune Globulin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Animal-derived Immune Globulin Distributors
- 12.2.3 Animal-derived Immune Globulin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst